TW200640452A - Antifungal compositions - Google Patents
Antifungal compositionsInfo
- Publication number
- TW200640452A TW200640452A TW095106521A TW95106521A TW200640452A TW 200640452 A TW200640452 A TW 200640452A TW 095106521 A TW095106521 A TW 095106521A TW 95106521 A TW95106521 A TW 95106521A TW 200640452 A TW200640452 A TW 200640452A
- Authority
- TW
- Taiwan
- Prior art keywords
- hydrocortisone
- mixtures
- pharmaceutically acceptable
- effective amount
- antifungal compositions
- Prior art date
Links
- 239000012871 anti-fungal composition Substances 0.000 title 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 229960000890 hydrocortisone Drugs 0.000 abstract 2
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- -1 quinolone compound Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960005429 sertaconazole Drugs 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
- H01J1/02—Main electrodes
- H01J1/30—Cold cathodes, e.g. field-emissive cathode
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Manufacturing & Machinery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05101540A EP1698336A1 (en) | 2005-03-01 | 2005-03-01 | Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200640452A true TW200640452A (en) | 2006-12-01 |
Family
ID=34938848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095106521A TW200640452A (en) | 2005-03-01 | 2006-02-27 | Antifungal compositions |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080166398A1 (zh) |
| EP (2) | EP1698336A1 (zh) |
| JP (1) | JP2008531640A (zh) |
| KR (1) | KR20070107806A (zh) |
| CN (1) | CN101137362A (zh) |
| AR (1) | AR053688A1 (zh) |
| AU (1) | AU2006219903A1 (zh) |
| BR (1) | BRPI0607561A2 (zh) |
| CA (1) | CA2598598A1 (zh) |
| MX (1) | MX2007010703A (zh) |
| NO (1) | NO20074945L (zh) |
| PE (1) | PE20061241A1 (zh) |
| RU (1) | RU2007136169A (zh) |
| TW (1) | TW200640452A (zh) |
| UY (1) | UY29402A1 (zh) |
| WO (1) | WO2006092374A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8057433B2 (en) | 2004-07-08 | 2011-11-15 | Drugtech Corporation | Delivery system |
| US20110212933A1 (en) * | 2008-03-20 | 2011-09-01 | Allan Shapiro | Antiseptic Compositions for the Treatment of Infections |
| EP2177208A1 (en) | 2008-10-17 | 2010-04-21 | Ferrer Internacional, S.A. | Pharmaceutical topical compositions |
| RU2440108C2 (ru) * | 2009-11-12 | 2012-01-20 | Общество с ограниченной ответственностью "ШТАДА ФармДевелопмент" | Фармацевтическая композиция для лечения аллергических и воспалительных заболеваний кожи |
| CN103156862B (zh) * | 2013-03-28 | 2015-04-29 | 孙国栋 | 一种复方伏立康唑滴耳剂及其制备方法 |
| KR20170117077A (ko) * | 2015-02-13 | 2017-10-20 | 마루호 코 엘티디 | 피리돈카르복실산계 유도체를 함유하는 외용제 |
| CN109562058A (zh) * | 2016-07-08 | 2019-04-02 | 方济各安吉利克化学联合股份有限公司 | 包含苄达明的药物组合物 |
| CN113520993B (zh) * | 2021-07-30 | 2022-07-29 | 海南海神同洲制药有限公司 | 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407663A (en) * | 1991-04-11 | 1995-04-18 | Eisen; Drore | Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents |
| US5578315A (en) * | 1993-12-01 | 1996-11-26 | Rutgers, The State University Of New Jersey | Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
| CN1152029C (zh) * | 1998-04-06 | 2004-06-02 | 富山化学工业株式会社 | 喹喏酮羧酸衍生物及其盐 |
| JP2005501883A (ja) * | 2001-09-04 | 2005-01-20 | トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル | セルタコナゾールを含む爪の機能障害および疾患の治療用の膏薬 |
| US20030091540A1 (en) * | 2001-10-16 | 2003-05-15 | Nawaz Ahmad | Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| ES2203316B1 (es) * | 2002-02-11 | 2005-03-01 | Ferrer Internacional, S.A. | R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol. |
| WO2004058262A1 (en) * | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| EP1635770B1 (en) * | 2003-03-21 | 2009-05-27 | Nexmed Holdings, Inc. | Antifungal nail coat and method of use |
-
2005
- 2005-03-01 EP EP05101540A patent/EP1698336A1/en not_active Withdrawn
-
2006
- 2006-02-22 CA CA002598598A patent/CA2598598A1/en not_active Abandoned
- 2006-02-22 RU RU2007136169/15A patent/RU2007136169A/ru unknown
- 2006-02-22 MX MX2007010703A patent/MX2007010703A/es not_active Application Discontinuation
- 2006-02-22 BR BRPI0607561-4A patent/BRPI0607561A2/pt not_active Application Discontinuation
- 2006-02-22 JP JP2007557469A patent/JP2008531640A/ja active Pending
- 2006-02-22 EP EP06724865A patent/EP1858510A1/en not_active Withdrawn
- 2006-02-22 KR KR1020077022419A patent/KR20070107806A/ko not_active Withdrawn
- 2006-02-22 CN CNA2006800066676A patent/CN101137362A/zh active Pending
- 2006-02-22 AU AU2006219903A patent/AU2006219903A1/en not_active Abandoned
- 2006-02-22 WO PCT/EP2006/060190 patent/WO2006092374A1/en not_active Ceased
- 2006-02-22 US US11/885,554 patent/US20080166398A1/en not_active Abandoned
- 2006-02-24 UY UY29402A patent/UY29402A1/es unknown
- 2006-02-27 PE PE2006000226A patent/PE20061241A1/es not_active Application Discontinuation
- 2006-02-27 TW TW095106521A patent/TW200640452A/zh unknown
- 2006-03-01 AR ARP060100758A patent/AR053688A1/es unknown
-
2007
- 2007-10-01 NO NO20074945A patent/NO20074945L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1858510A1 (en) | 2007-11-28 |
| KR20070107806A (ko) | 2007-11-07 |
| EP1698336A1 (en) | 2006-09-06 |
| RU2007136169A (ru) | 2009-04-10 |
| CN101137362A (zh) | 2008-03-05 |
| CA2598598A1 (en) | 2006-09-08 |
| US20080166398A1 (en) | 2008-07-10 |
| MX2007010703A (es) | 2007-10-12 |
| PE20061241A1 (es) | 2006-11-13 |
| AU2006219903A1 (en) | 2006-09-08 |
| JP2008531640A (ja) | 2008-08-14 |
| WO2006092374A1 (en) | 2006-09-08 |
| NO20074945L (no) | 2007-11-21 |
| UY29402A1 (es) | 2006-06-30 |
| AR053688A1 (es) | 2007-05-16 |
| BRPI0607561A2 (pt) | 2009-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074945L (no) | Antifungal sammensetning omfattende sertaconalzol og hydrokortison og/eller en antibakteriell kinolinforbindelse | |
| WO2004062601A3 (en) | Antibacterial agents | |
| ECSP077239A (es) | Formulación farmacéutica | |
| EP2662353A3 (en) | Antibacterial agents | |
| WO2012032360A3 (en) | Novel use | |
| WO2003091276A3 (en) | Compositions and methods of use of peptides in combination with biocides and/or germicides | |
| EP2279662A3 (en) | 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent | |
| WO2018208987A3 (en) | Antibacterial compounds | |
| WO2007138110A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| WO2020061375A8 (en) | Antibacterial compounds | |
| WO2011047439A8 (en) | Novel parasite therapy | |
| WO2007134777A3 (de) | Fungizide wirkstoffkombinationen | |
| EP2889034A3 (en) | Compositions and methods of treatment comprising ceftaroline | |
| WO2007138112A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
| MY136090A (en) | Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide drivative | |
| AR064152A1 (es) | Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion. | |
| WO2010036000A3 (en) | Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof | |
| WO2011042473A3 (en) | Estrogen receptor ligands | |
| WO2010030811A3 (en) | CARBACEPHEM β-LACTAM ANTIBIOTICS | |
| WO2007064620A3 (en) | Compositions comprising a combination of ccr5 and cxcr4 antagonists | |
| WO2009038411A3 (en) | Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety | |
| WO2007047881A3 (en) | Method for treating neuropathic pain | |
| AU2021902274A0 (en) | Wool Harvesting 1 200726 | |
| AU2021901348A0 (en) | Wool Harvesting 3 210605 | |
| AU2021901347A0 (en) | Wool Harvesting 5 |